Document Detail

A variant course of the superficial palmar branch of the radial artery.
MedLine Citation:
PMID:  22179903     Owner:  NLM     Status:  Publisher    
The objective of this report was to present a case of superficial palmar branch of the radial artery (SPBRA) with a variant course, which to the best of our knowledge, has not been reported in the literature. During anatomical dissections that were carried out in the Department of Anatomy of Suleyman Demirel University School of Medicine to demonstrate the superficial palmar arch, a variation in the course of the SPBRA was noted in the right hand of an adult cadaver. This variant branch ran superficial to, and in contact with, the flexor retinaculum, and ran transversely to join the ulnar artery.
Suleyman Murat Tagil; Mehmet Cem Bozkurt; Samet Vasfi Kuvat; Aynur Emine Cicekcibasi
Related Documents :
1255323 - Persistent fetal circulation: newly recognized structural features.
17065143 - Pulmonary hypertension in a child with juvenile myelomonocytic leukemia secondary to pu...
22169593 - Circulating biomarkers and abdominal aortic aneurysm size.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-18
Journal Detail:
Title:  Surgical and radiologic anatomy : SRA     Volume:  -     ISSN:  1279-8517     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8608029     Medline TA:  Surg Radiol Anat     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Anatomy, Faculty of Medicine, Fatih University, Anadolu Bulvarı 16/A Gimat, 06370, Yenimahalle, Ankara, Turkey,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multidetector CT imaging of arterial supply to sinuatrial and atrioventricular nodes.
Next Document:  Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell n...